Researchers from the Daegu Gyeongbuk Institute of Science and Technology (DGIST) and the Pohang University of Science and Technology (POSTECH) have developed a novel 3D biomimetic skeletal muscle microtissue model designed to replicate the physiological changes associated with human aging. Published in the journal Small Science, the study offers a new approach to investigating sarcopenia, a condition characterized by the age-related decline in muscle mass and contractile function. By utilizing human-derived cells, the team established a platform that mirrors the morphological and functional characteristics of muscle tissue in older individuals, providing a viable alternative to traditional animal testing methods.
To create the artificial muscle model, the research team, led by Professor Minseok S. Kim of the DGIST Department of New Biology and Professor Dong-Woo Cho of the POSTECH Department of Mechanical Engineering, obtained muscle cells from two male donors aged 17 and 68 years. These cells were combined with a decellularized extracellular matrix, which served as a structural scaffold for the tissue formation. The mixture was cultured in customized 3D-printed molds, forcing the cells to align uniformly in a single direction, effectively mimicking the natural architecture of actual human skeletal muscle.
A comparative analysis of the resulting 3D tissues provided clear evidence of biological differences between the samples derived from the younger and older donors. Tissues cultured from the 68-year-old donor cells demonstrated significantly thinner muscle fibers and a reduced rate of cell fusion compared to those derived from the 17-year-old donor.
Beyond morphological changes, the research team conducted functional evaluations to observe how the tissues responded to external stimuli. The results indicated that tissues derived from the older donor experienced impaired mitochondrial function, which is critical for cellular energy production. The team also observed retarded calcium responses, the mechanism that triggers muscle fiber contraction. Consequently, the tissues produced from older donor cells showed a marked reduction in contractile force when subjected to electrical stimulation, demonstrating that the model could replicate the functional decline characteristic of sarcopenia.
This experimental platform is distinct from conventional methods, which typically involve culturing cells on flat 2D surfaces that fail to replicate the three-dimensional movements and contractile mechanics of human muscle. By enabling the simultaneous evaluation of morphological, molecular, and functional changes within a single 3D environment, the study provides a comprehensive approach to modeling the aging process.
The study arrives at a significant time for pharmaceutical research, particularly as the U.S. Food and Drug Administration (FDA) has updated its regulatory framework under the FDA Modernization Act 2.0 to permit drug approval applications without mandatory animal testing. The development of an artificial muscle model that reflects human physiological characteristics is expected to be a valuable asset in the ongoing effort to develop and validate therapeutics for muscle-related aging conditions, including sarcopenia.
Skeletal muscles, which attach to bones and enable body movement, also play a crucial role in overall metabolic regulation. The onset of sarcopenia, marked by age-related declines in muscle mass and functional capacity, reduces mobility and severely undermines quality of life in old age. “The significance of this study lies in establishing a foundation for faithfully replicating age-related changes using human-derived cells and evaluating both cellular-level changes and actual muscle contractile function,” Kim stated. He noted that given the increasing global interest in human-centered nonclinical testing methods that can replace animal experiments, the team aims to refine this model into a valuable research tool for identifying the causes of muscle aging and accurately validating the efficacy of candidate therapeutics.
The collaborative project brought together researchers from the Department of New Biology at DGIST, led by President Kunwoo Lee, and the Department of Mechanical Engineering at POSTECH. The research was supported by the National Research Foundation of Korea. Sohae Yang, an integrated master’s–doctoral student in the Department of New Biology at DGIST, and Dr. Jeong Sik Kong of the Department of Mechanical Engineering at POSTECH served as co-first authors of the paper. Recognizing its technological and academic value, the study, titled “A Biomimetic 3D Human Skeletal Muscle Microtissue for Modeling Biological and Functional Hallmarks of Aging,” was selected as the front cover article in the journal Small Science.
Subject of Research: Development of a 3D biomimetic human skeletal muscle model to study sarcopenia.
Article Title: “Studying human muscle aging without animal experiments”: DGIST develops a 3D biomimetic aging muscle model
Article References: “Studying human muscle aging without animal experiments”: DGIST develops a 3D biomimetic aging muscle model. Original publication (Bibliographic details unavailable.)
Image Credits: AI Generated
DOI: Not provided
Keywords: Biomimetic Engineering, Skeletal Muscle, Sarcopenia, Human Aging, 3D Bioprinting, Cell Biology, Mitochondrial Dysfunction, Muscle Contraction, Nonclinical Testing, Decellularized Extracellular Matrix, Muscle Fibers, Regenerative Medicine, FDA Modernization Act, Tissue Engineering, Molecular Biology
News Source: Drew Townsend. (November 16, 2026). 3D Biomimetic Muscle Model Successfully Replicates Human Sarcopenia Hallmarks Without Animals. Scienmag.



